Renal Cancer - Results from #6020

Early Tumor Shrinkage Under Treatment with First-line Tyrosine Kinase Inhibitors as a Predictor of Overall Survival in Patients with Metastatic Renal Cell Carcinoma: a Retrospective Multi-Institutional Study in Japan September 21, 2015

National Trends of Local Ablative Therapy among Young Patients with Small Renal Masses in the United States September 21, 2015

FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma September 21, 2015

Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association September 21, 2015

Renal cell carcinoma in patients with a personal or family history of hematologic malignancies September 17, 2015

Non-clear cell renal cell carcinoma, part 2: therapy September 17, 2015

Non-clear cell renal cell carcinoma, part 1: histology September 17, 2015

Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma September 17, 2015

RandomizEd phase 2 trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trial September 17, 2015

Activity of aminoferrocene-based prodrugs against prostate cancer September 8, 2015

Prediction of Complications Following Partial Nephrectomy: Implications for Ablative Techniques Candidates September 8, 2015

Tubulocystic renal cell carcinoma is an entity immunohistochemically and genetically distinct from papillary renal cell carcinoma September 4, 2015

Retrospective Analysis of the Efficacy and Safety of Sorafenib in Chinese Patients With Metastatic Renal Cell Carcinoma and Prognostic Factors Related to Overall Survival September 3, 2015

PD-1 and PD-L1 Expression in Renal Cell Carcinoma With Sarcomatoid Differentiation September 2, 2015

Risk Factors for Recurrence After Surgery in Non- metastatic RCC with Thrombus; a Contemporary Multicenter Analysis September 2, 2015

Hypertension and Circulating Cytokines and Angiogenic Factors in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Results From a Phase II Trial September 1, 2015

Therapeutic challenges in renal cell carcinoma September 1, 2015

Health Care Costs Among Renal Cancer Patients Using Pazopanib and Sunitinib September 1, 2015

Cost-Effectiveness of Pazopanib Versus Sunitinib for Renal Cancer in the United States September 1, 2015

Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality Following Radical Nephrectomy for Localized Renal Cell Cancer September 1, 2015

Page 302 of 456